Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kinross Gold | 5.58% | $3.44M | $41.74B | 204.92% | 81 Outperform | |
| Novartis AG | 4.48% | $2.76M | CHF242.43B | 30.85% | 80 Outperform | |
| Rio Tinto Limited | 4.38% | $2.70M | AU$238.88B | 54.36% | 78 Outperform | |
| Nutrien | 4.20% | $2.59M | C$46.56B | 35.05% | 75 Outperform | |
| BAE Systems | 4.19% | $2.58M | £61.53B | 72.63% | 61 Neutral | |
| Sumitomo Mitsui Financial Group | 3.60% | $2.22M | ¥22.61T | 60.80% | 77 Outperform | |
| Mitsubishi Electric | 3.29% | $2.03M | ¥11.82T | 115.93% | 72 Outperform | |
| Rexel SA | 3.14% | $1.93M | €10.60B | 35.86% | 65 Neutral | |
| AstraZeneca | 3.08% | $1.90M | £240.98B | 31.92% | 80 Outperform | |
| Nordea Bank Abp | 2.97% | $1.83M | kr611.49B | 48.76% | ― |